National Trauma Research Institute, Melbourne, Victoria, Australia.
Emergency and Trauma Centre, The Alfred Hospital, Melbourne, Victoria, Australia.
Emerg Med Australas. 2021 Aug;33(4):728-733. doi: 10.1111/1742-6723.13809. Epub 2021 Jun 2.
In response to COVID-19, we introduced and examined the effect of a raft of modifications to standard practice on adverse events and first-attempt success (FAS) associated with ED intubation.
An analysis of prospectively collected registry data of all ED intubations over a 3-year period at an Australian Major Trauma Centre. During the first 6 months of the COVID-19 pandemic in Australia, we introduced modifications to standard practice to reduce the risk to staff including: aerosolisation reduction, comprehensive personal protective equipment for all intubations, regular low fidelity simulation with 'sign-off' for all medical and nursing staff, senior clinician laryngoscopist and the introduction of pre-drawn medications.
There were 783 patients, 136 in the COVID-19 era and 647 in the pre-COVID-19 comparator group. The rate of hypoxia was higher during the COVID-19 era compared to pre-COVID-19 (18.4% vs 9.6%, P < 0.005). This occurred despite the FAS rate remaining very high (95.6% vs 93.8%, P = 0.42) and intubation being undertaken by more senior laryngoscopists (consultant 55.9% during COVID-19 vs 22.6% pre-COVID-19, P < 0.001). Other adverse events were similar before and during COVID-19 (hypotension 12.5% vs 7.9%, P = 0.082; bradycardia 1.5% vs 0.5%, P = 0.21). Video laryngoscopy was more likely to be used during COVID-19 (95.6% vs 82.5%, P < 0.001) and induction of anaesthesia more often used ketamine (66.9% vs 42.3%, P < 0.001) and rocuronium (86.8% vs 52.1%, P < 0.001).
This raft of modifications to ED intubation was associated with significant increase in hypoxia despite a very high FAS rate and more senior first laryngoscopist.
针对 COVID-19,我们引入并研究了对标准操作进行一系列修改对急诊科插管相关不良事件和首次尝试成功率(FAS)的影响。
对澳大利亚一家大型创伤中心 3 年内所有急诊科插管的前瞻性收集登记数据进行分析。在澳大利亚 COVID-19 大流行的前 6 个月,我们引入了一些标准操作修改,以降低员工风险,包括:减少气溶胶化、所有插管均使用全面的个人防护设备、所有医护人员定期进行低保真度模拟并进行“签名”、资深临床医生进行喉镜检查以及预先绘制药物。
共有 783 名患者,136 名在 COVID-19 时期,647 名在 COVID-19 前的对照组。COVID-19 时期的缺氧发生率高于 COVID-19 前(18.4%比 9.6%,P<0.005)。尽管 FAS 率仍然非常高(95.6%比 93.8%,P=0.42),并且插管由更资深的喉镜检查者进行(COVID-19 期间顾问占 55.9%,COVID-19 前为 22.6%,P<0.001),但仍出现这种情况。其他不良事件在 COVID-19 前后相似(低血压 12.5%比 7.9%,P=0.082;心动过缓 1.5%比 0.5%,P=0.21)。在 COVID-19 期间更有可能使用视频喉镜(95.6%比 82.5%,P<0.001),并且更常使用氯胺酮诱导麻醉(66.9%比 42.3%,P<0.001)和罗库溴铵(86.8%比 52.1%,P<0.001)。
尽管首次尝试成功率很高且首次喉镜检查者更为资深,但对急诊科插管进行的这一系列修改与缺氧发生率的显著增加有关。